CleanSpace Holdings Limited (CSX.AX)
AUD 0.42
(13.51%)
AUD 0.42
(13.51%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 6.94 Million AUD | -1.0% |
| 2023 | 7.01 Million AUD | -18.4% |
| 2022 | 8.6 Million AUD | -13.87% |
| 2021 | 9.98 Million AUD | -3.96% |
| 2020 | 10.4 Million AUD | 168.85% |
| 2019 | 3.86 Million AUD | 16.51% |
| 2018 | 3.32 Million AUD | 8.17% |
| 2017 | 3.06 Million AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 7.49 Million AUD | -12.85% |
| 2024 Q4 | 6.94 Million AUD | 0.0% |
| 2024 FY | 6.94 Million AUD | -1.0% |
| 2024 Q3 | 6.94 Million AUD | -7.3% |
| 2024 Q2 | 7.49 Million AUD | 0.0% |
| 2023 Q4 | 8.6 Million AUD | 22.55% |
| 2023 Q2 | 7.69 Million AUD | 0.0% |
| 2023 FY | 7.01 Million AUD | -18.4% |
| 2023 Q1 | 7.69 Million AUD | -10.55% |
| 2023 Q3 | 7.01 Million AUD | -8.77% |
| 2022 Q4 | 8.6 Million AUD | 0.0% |
| 2022 Q3 | 8.6 Million AUD | 6.05% |
| 2022 Q2 | 8.11 Million AUD | 0.0% |
| 2022 Q1 | 8.11 Million AUD | -18.78% |
| 2022 FY | 8.6 Million AUD | -13.87% |
| 2021 Q1 | 18.19 Million AUD | 37.66% |
| 2021 FY | 9.98 Million AUD | -3.96% |
| 2021 Q2 | 18.19 Million AUD | 0.0% |
| 2021 Q4 | 9.98 Million AUD | 0.0% |
| 2021 Q3 | 9.98 Million AUD | -45.1% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 Q3 | 13.21 Million AUD | 0.0% |
| 2020 Q4 | 13.21 Million AUD | 0.0% |
| 2020 FY | 10.4 Million AUD | 168.85% |
| 2019 FY | 3.86 Million AUD | 16.51% |
| 2018 FY | 3.32 Million AUD | 8.17% |
| 2017 FY | 3.06 Million AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 85.843% |
| Adherium Limited | 3.4 Million AUD | -103.998% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 52.975% |
| Atomo Diagnostics Limited | 1.29 Million AUD | -436.91% |
| Anteris Technologies Ltd | 17.03 Million AUD | 59.213% |
| Control Bionics Limited | 2.75 Million AUD | -151.838% |
| CardieX Limited | 8.56 Million AUD | 18.834% |
| Compumedics Limited | 22.14 Million AUD | 68.621% |
| Cochlear Limited | 904.6 Million AUD | 99.232% |
| Cyclopharm Limited | 13.65 Million AUD | 49.104% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | -27.386% |
| Nova Eye Medical Limited | 8.55 Million AUD | 18.736% |
| HeraMED Limited | 1.5 Million AUD | -361.488% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 72.206% |
| ImpediMed Limited | 6.24 Million AUD | -11.32% |
| InhaleRx Limited | 911.41 Thousand AUD | -662.521% |
| LBT Innovations Limited | 5.5 Million AUD | -26.175% |
| Micro-X Limited | 12.63 Million AUD | 44.992% |
| Neurotech International Limited | 314.69 Thousand AUD | -2108.371% |
| OncoSil Medical Limited | 1.98 Million AUD | -250.643% |
| PolyNovo Limited | 37.04 Million AUD | 81.239% |
| Respiri Limited | 3.55 Million AUD | -95.548% |
| SomnoMed Limited | 24.78 Million AUD | 71.955% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 34.514% |
| Uscom Limited | 2.07 Million AUD | -235.156% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | -151.173% |